Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-597-8 | CAS number: 108-59-8
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Additional information
In the combined repeated dose reproduction/developmental screening test with dimethylmalonate in Wistar rats no treatment related changes in fertility index for males and females, gestation index, testes and epididymis weights were observed compared to the control. No treatment related histopathological changes of the sex organs or stages of spermatogenesis were reported (Degussa, 2003). The NOAEL for fertility corresponds therefore to the highest dose tested: 1000 mg/kg bw per day.
Short description of key information:
OECD TG 422 (GLP), oral, rat: NOAEL (fertility) = 1000 mg/kg bw.
Effects on developmental toxicity
Description of key information
OECD TG 422 (GLP), oral, rat:
NOAEL (maternal toxicity) = 300 mg/kg bw.
NOAEL (developmental toxicity) = 1000 mg/kg bw.
Additional information
The combined repeated dose reproduction/developmental screening test with dimethylmalonate in Wistar rats revealed no treatment related changes in the duration of gestation, the gestation index, parturition and pre-implantation loss compared to controls. In the low dose group post-implantation loss was increased and consequently the percentage of live pups born was statistically significantly reduced compared to controls. These changes were considered incidental and not treatment related as the effects were not observed in the mid and high dose groups. No statistically significant differences between treated and control groups were observed for the number of pregnancies, number of dams that littered, number of live litters, mean litter size, mean viable litter size, sex ratio at birth, number of pups dead at first observation or day 2 to 4 post partum, number of live pups at day 0, 3, and 4 post partum and the associated survival indices. A significantly higher percentage of male pups and lower number of females on day 4 post partum in the low dose group was considered incidental as no comparable change was observed in the mid and high dose group or at other time intervals. The mean number and mean weights of male and female pups as well as both sexes combined were otherwise not statistically significantly different from controls. No statistically significant difference in the external abnormalities of life and dead pups compared to controls was observed at all dose levels. Maternal toxicity was restricted to a reversible hepatocellular hypertrophy at 1000 mg/kg bw, with a maternal NOAEL of 300 mg/kg bw. The NOAEL for developmental toxicity was 1000 mg/kg bw per day (Degussa, 2003).
Justification for classification or non-classification
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
